Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum.
暂无分享,去创建一个
M. Karp | Pirjo Laaksonen | S. Käkönen | K. Pettersson | T. Lövgren | K. Obrant | J. Hellman | K J Obrant | T Lövgren | K Pettersson | H. Väänänen | J Hellman | M Karp | H K Väänänen | S M Käkönen | P Laaksonen | P. Laaksonen | T. Lövgren
[1] D. Seligson,et al. Clinical Chemistry , 1965, Bulletin de la Societe de chimie biologique.
[2] P. Delmas,et al. Measurement of serum osteocalcin with a human‐specific two‐site immunoradiometric assay , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] Z. Verjee,et al. Lidocaine and HPLC assay for anticonvulsants. , 1994, Clinical chemistry.
[4] C. de la Piedra,et al. Six osteocalcin assays compared. , 1994, Clinical chemistry.
[5] J. Burrin,et al. Effect of different storage temperatures, sample collection procedures and immunoassay methods on osteocalcin measurement. , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[6] P. Price,et al. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. , 1981, The Journal of biological chemistry.
[7] P. Fottrell,et al. Osteocalcin: diagnostic methods and clinical applications. , 1991, Critical reviews in clinical laboratory sciences.
[8] K. Mann,et al. Comparison of monoclonal and polyclonal antibody‐based immunoassays for osteocalcin: A study of sources of variation in assay results , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[9] P. Garnero,et al. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. , 1997, The Journal of clinical endocrinology and metabolism.
[10] R. Eastell,et al. Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays. , 1995, Clinical chemistry.
[11] M. Mizruchi,et al. Osteocalcin in human serum: a circadian rhythm. , 1985, The Journal of clinical endocrinology and metabolism.
[12] R. Wolfert,et al. Two-site assays of bone gla protein (osteocalcin) demonstrate immunochemical heterogeneity of the intact molecule. , 1992, Clinical chemistry.
[13] R. Jones,et al. Commercial assays for serum osteocalcin give clinically discordant results. , 1994, Clinical chemistry.
[14] R. J. Williams,et al. Conformational studies of osteocalcin in solution. , 1995, European journal of biochemistry.
[15] J. Body,et al. Technical and clinical validation of a new immunoradiometric assay for human osteocalcin. , 1996, European journal of endocrinology.
[16] N. Ling,et al. Isolation and sequence of the vitamin K-dependent protein from human bone. Undercarboxylation of the first glutamic acid residue. , 1980, The Journal of biological chemistry.
[17] D. Vanderschueren,et al. Homologous radioimmunoassay of human osteocalcin. , 1992, Clinical chemistry.
[18] D. Thompson,et al. Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. , 1994, Endocrinology.
[19] S. Carr,et al. Calcium-dependent alpha-helical structure in osteocalcin. , 1982, Biochemistry.
[20] J. Astermark,et al. The Proportion of Carboxylated to Total or Intact Osteocalcin in Serum Discriminates Warfarin‐Treated Patients from Control Subjects , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] C. Christiansen,et al. Bone gla protein (osteocalcin) assay standardization report , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] K. Hamulýak,et al. The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. , 1989, Annals of internal medicine.
[23] P. Delmas,et al. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[24] Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. , 1998, The Journal of clinical endocrinology and metabolism.
[25] W. Fraser,et al. Differences in the Stability of Intact Osteocalcin in Serum, Lithium Heparin Plasma and EDTA Plasma , 1995, Annals of clinical biochemistry.
[26] C. Egsmose,et al. Determination of bone Gla protein (osteocalcin) by enzyme-linked immunosorbent assay. , 1989, Clinica chimica acta; international journal of clinical chemistry.
[27] S. Booth,et al. Diurnal Variation in Total and Undercarboxylated Osteocalcin: Influence of Increased Dietary Phylloquinone , 1998, Calcified Tissue International.
[28] M. Karp,et al. Epitope mapping of nine monoclonal antibodies against osteocalcin: Combinations into two‐site assays affect both assay specificity and sample stability , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[29] P. Delmas,et al. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. , 1993, The Journal of clinical investigation.
[30] J. Gosling,et al. Radioimmunoassay of osteocalcin with polyclonal and monoclonal antibodies. , 1989, Clinical chemistry.